Medicare hospital outpatient rate set for Argus II

The Medicare hospital outpatient rate for the Argus II retinal prosthesis system has been set at $152,500 by CMS, Second Sight Medical Products announced in a press release.
Argus II is the only FDA- and CE mark-approved device for the treatment of retinitis pigmentosa.
“We are delighted to have received CMS’ final 2019 outpatient payment rate, which provides Medicare patients continued access to our life-changing technology,” Will McGuire, Second Sight CEO and president, said in the release. “We are also happy to see the change in methodology that considers multiple

Full Story →